These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2463481)

  • 21. Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen.
    Laferté S; Krantz MJ
    Mol Immunol; 1983 Apr; 20(4):421-31. PubMed ID: 6191208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion.
    Zhou H; Stanners CP; Fuks A
    Cancer Res; 1993 Aug; 53(16):3817-22. PubMed ID: 7687926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor specificity of monoclonal antibodies to carcinoembryonic antigen. Immunohistochemical analysis.
    Zoubir F; Zeromski J; Sikora J; Szmeja J; Hedin A; Hammarström S
    Tumour Biol; 1990; 11(1-2):5-19. PubMed ID: 2408131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
    Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
    Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen.
    Hedin A; Hammarström S; Larsson A
    Mol Immunol; 1982 Dec; 19(12):1641-8. PubMed ID: 6186908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system.
    de Moraes JZ; Carneiro CR; Buchegger F; Mach JP; Lopes JD
    J Cell Biochem; 1992 Nov; 50(3):324-35. PubMed ID: 1281819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel CEA-cross-reacting antigen of molecular weight 140,000 expressed on human lymphoid cell lines.
    Kuroki M; Matsuo Y; Ohtani T; Minowada J; Kuroki M; Matsuoka Y
    Mol Immunol; 1990 Jul; 27(7):689-96. PubMed ID: 2168514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
    Audette M; Buchegger F; Schreyer M; Mach JP
    Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of new antigenic fragments related to carcinoembryonic antigen in adult feces.
    Henslee JG; Vachula EJ; Paxton RJ; Matias MS; Shively JE; Rittenhouse HG; Tomita JT
    Cancer Res; 1992 Aug; 52(15):4175-82. PubMed ID: 1379120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactivity of recombinant carcinoembryonic antigen proteins expressed in Escherichia coli.
    Kuroki M; Murakami M; Wakisaka M; Ikeda S; Oikawa S; Oshima T; Nakazato H; Kosaki G; Matsuoka Y
    Immunol Invest; 1992 Jun; 21(3):241-57. PubMed ID: 1375188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen.
    Gaida FJ; Fenger U; Wagener C; Neumaier M
    Int J Cancer; 1992 May; 51(3):459-65. PubMed ID: 1592535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping epitope characteristics on carcinoembryonic antigen.
    Harwood PJ; Britton DW; Southall PJ; Boxer GM; Rawlins G; Rogers GT
    Br J Cancer; 1986 Jul; 54(1):75-82. PubMed ID: 2425837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological and biochemical characterization of recombinant baculovirus carcinoembryonic antigen.
    Bei R; Kantor J; Kashmiri SV; Schlom J
    Mol Immunol; 1994 Jul; 31(10):771-80. PubMed ID: 7518569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and characterization of chimeric anti-carcinoembryonic antigen monoclonal antibodies and their Fab fragments.
    Kamigaki T; Ohyanagi H; Yamamoto M; Kaneda T; Goto T; Ohmura T; Yokoyama K; Saitoh Y
    Jpn J Cancer Res; 1994 Mar; 85(3):298-305. PubMed ID: 8188529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A reference of the GOLD classification of monoclonal antibodies against carcinoembryonic antigen to the domain structure of the carcinoembryonic antigen molecule.
    Murakami M; Kuroki M; Arakawa F; Kuwahara M; Oikawa S; Nakazato H; Matsuoka Y
    Hybridoma; 1995 Feb; 14(1):19-28. PubMed ID: 7768530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Internal image-bearing anti-idiotypic monoclonal antibodies.
    Hinoda Y; Tsujisaki M; Imai K; Yachi A
    Tumour Biol; 1995; 16(1):48-55. PubMed ID: 7863222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule.
    Kuroki M; Arakawa F; Haruno M; Murakami M; Wakisaka M; Higuchi H; Oikawa S; Nakazato H; Matsuoka Y
    Hybridoma; 1992 Aug; 11(4):391-407. PubMed ID: 1383122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of fragments of carcinoembryonic antigen and identification of a major subset of antigenic determinants.
    Krantz MJ; Laferté S
    Mol Immunol; 1983 Apr; 20(4):409-20. PubMed ID: 6191207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD.
    Buchegger F; Schreyer M; Carrel S; Mach JP
    Int J Cancer; 1984 May; 33(5):643-9. PubMed ID: 6724739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of monoclonal antibodies specific to synthetic peptide of carcinoembryonic antigen.
    Tsujisaki M; Imai K; Hishikawa N; Tokuchi S; Hinoda Y; Matsukawa H; Oikawa S; Nakazato H; Yachi A
    Int J Cancer; 1991 Jan; 47(2):267-73. PubMed ID: 1703128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.